Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Human vaccines & immunotherapeutics
- Publicado em
- 2 jan 2023
- Citações
- 8
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
Dapeng Sun, Dan Yu, Zhenhua Du, Ningning Jia, Xiaodong Liu, Jianwen Sun, Qing Xu, Zhuoqun Sun, Chunfang Luan, Jingjing Lv et al.
Descritores MeSH
- Herpes Zoster Vaccine
- Viral Vaccines
- Child
- Humans
- Vaccines, Attenuated
- Immunogenicity, Vaccine
- Vaccines, Inactivated
- Chickenpox Vaccine
- Hepatitis A Vaccines
- Hepatitis A Antibodies
Veja também
Estudos relacionados
- A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country
- Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
- Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older: A randomized, double-blind, controlled study
- Imunogenicidade e segurança da hepatite inactivada TZ84- vs. HM175 Vacinas em populações pediátricas: Revisão sistemática e meta-análise